The present application describes modulators of MCP-1 or CCR-2 of formula (I) or stereoisomers or prodrugs or pharmaceutically acceptable salts thereof, wherein W
1
, W
2
, W
3
, Y, Z, R
2
, R
3
, R
3
′ and R
4
, are defined in the specification. In addition, methods of treating and preventing inflammatory diseases such as asthma and allergic diseases, as well as autoimmune pathologies such as rheumatoid arthritis and transplant rejection using modulators of formula (I) are disclosed.
本申请描述了 MCP-1 或 CCR-2 的调节剂,其
化学式为(I)或其立体异构体或前药或药学上可接受的盐,其中 W1、W2、W3、Y、Z、R2、R3、R3'和 R4 在说明书中有定义。此外,还公开了使用化合物(I)的调节剂治疗和预防炎症性疾病,如哮喘和过敏性疾病,以及自身免疫病理,如类风湿关节炎和移植排斥等的方法。